USA - NASDAQ:ENLV - IL0011319527 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ENLV. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2025-10-29 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-09-26 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-09-12 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2025-08-22 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-08-18 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-07-29 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-07-22 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-04-21 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-04-03 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-03-24 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2025-03-03 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2025-02-07 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2024-12-11 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2024-12-03 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2024-11-14 | D. Boral Capital | Maintains | Buy -> Buy | 
| 2024-09-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-09-26 | EF Hutton | Maintains | Buy -> Buy | 
| 2024-09-24 | EF Hutton | Maintains | Buy -> Buy | 
| 2024-09-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-08-27 | EF Hutton | Initiate | Buy | 
| 2024-06-11 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2024-04-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2024-04-12 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-09-25 | HC Wainwright & Co. | Maintains | Buy -> Buy | 
| 2023-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy | 
| 2023-04-24 | HC Wainwright & Co. | Reiterate | Buy | 
| 2023-04-05 | HC Wainwright & Co. | Reiterate | Buy | 
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy | 
| 2022-05-02 | HC Wainwright & Co. | Maintains | Buy | 
8 analysts have analysed ENLV and the average price target is 10.2 USD. This implies a price increase of 880.77% is expected in the next year compared to the current price of 1.04.
The consensus rating for ENLIVEX THERAPEUTICS LTD (ENLV) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.